Literature DB >> 3391105

A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay.

R Danesi1, M Gasperini, S Senesi, G Freer, C A Angeletti, M Del Tacca.   

Abstract

A microbiological assay was undertaken to measure the amounts of clofoctol in human plasma and pulmonary tissue, and to investigate its pharmacokinetics. Clofoctol was extracted from samples using ethanol and the concentration of drug in the extracts was determined by the broth macrodilution method using as reference microorganisms S. aureus ATCC 29213 and B. cereus NCIB 8122, whose MIC values were 0.537 and 1.074 micrograms/ml respectively. This procedure allows the almost complete recovery of the drug and makes it possible to detect amounts of clofoctol as low as 5.5 micrograms/ml. Results indicate that clofoctol is well absorbed after a single rectal dose of 1.5 g, with a plasma Cmax at the 30th min after administration and an average AUC value of 80.91 micrograms/ml/h. The Cmax of lung tissue (which was higher than the plasmatic one) occurred at the 90th min and the average AUC value was 229.65 micrograms/ml/h, indicating good penetration of clofoctol into human lung tissue and appreciable tissue storage of the drug.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391105

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  4 in total

1.  The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13.

Authors:  Yan Hu; Meilian Zhang; Ningyu Tian; Dengke Li; Fan Wu; Peishan Hu; Zhixing Wang; Liping Wang; Wei Hao; Jingting Kang; Bin Yin; Zhi Zheng; Tao Jiang; Jiangang Yuan; Boqin Qiang; Wei Han; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

2.  Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.

Authors:  Jaeyeun Lee; John G Kosowicz; S Diane Hayward; Prashant Desai; Jennifer Stone; Jae Myun Lee; Jun O Liu; Richard F Ambinder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.

Authors:  Minghua Wang; Joong Sup Shim; Ruo-Jing Li; Yongjun Dang; Qingli He; Manisha Das; Jun O Liu
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

Authors:  Francesca D'Angelo; Valerio Baldelli; Nigel Halliday; Paolo Pantalone; Fabio Polticelli; Ersilia Fiscarelli; Paul Williams; Paolo Visca; Livia Leoni; Giordano Rampioni
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.